Favorable impact in hepatitis C–related mortality following free access to direct‐acting antivirals in Spain-Reference-Cited by-同舟云学术

Favorable impact in hepatitis C–related mortality following free access to direct‐acting antivirals in Spain

Published:2021-12-17 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Politi Julieta¹²³^ORCID,Guerras Juan‐Miguel¹⁴,Donat Marta³⁴,Belza María J.³⁴,Ronda Elena⁴⁵,Barrio Gregorio³⁴,Regidor Enrique⁴⁶⁷

Affiliation:

1. National Epidemiology Center Instituto de Salud Carlos III Madrid Spain

2. Preventive Medicine and Public Health Training Unit PSMar‐UPF‐ASPB (Parc de Salut Mar‐Pompeu Fabra University, Agència de Salut Pública de Barcelona) Barcelona Spain

3. National School of Public Health Instituto de Salud Carlos III Madrid Spain

4. CIBER Epidemiología y Salud Pública Madrid Spain

5. Preventive Medicine and Public Health Area Universidad de Alicante Alicante Spain

6. Department of Public Health & Maternal and Child Health Faculty of Medicine Universidad Complutense Madrid Spain

7. Instituto de Investigación Sanitaria del Hospital Clínico San Carlos Madrid Spain

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32237

Reference52 articles.

1. Hepatitis C;Spearman CW;Lancet,2019

2. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees;Dolan K;Lancet,2016

3. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review;Degenhardt L;Lancet Glob Health,2017

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Socioeconomic Deprivation Weighs Heavily on Liver Fibrosis and Mortality After Hepatitis C Cure (ANRS CO22 Hepather);Journal of Viral Hepatitis;2024-09-10

2. Evaluation of the clinical and economic value of sofosbuvir/velpatasvir (SOF/VEL) in patients with chronic hepatitis C in Spain during the last 5 years;Gastroenterología y Hepatología;2024-05

3. Epidemiological Perspectives: A Four-Year Insight Into Hepatitis C Surveillance in the Kingdom of Saudi Arabia;Cureus;2024-01-20

4. Hepatitis C virus cure from direct‐acting antivirals and mortality: Are people with and without a history of injection drug use in the same boat? (ANRS CO22 Hepather cohort);Drug and Alcohol Review;2023-12-22

5. The Efficiency of Increased HCV Testing and Treatment Strategies in Spain to Achieve Elimination Goals;PharmacoEconomics - Open;2023-12-15